Antibody Production Market to Reach USD 33.46 Billion by 2028 – Reports and Data

Rising prevalence of infectious diseases and increasing focus on production of therapeutic antibodies for treating cancer and other chronic diseases are key factors boosting global market growth

The global antibody production market size is expected to reach USD 33.46 Billion in 2028 and register a CAGR of 13.1%, according to the latest report by Reports and Data. Key factors such as rising investments in research and development activities and increasing demand for cost-effective therapeutic treatments are boosting global market revenue growth.   

Antibodies are extensively used in diagnostics, research, and therapeutic purposes due to key features such as high specificity, binding affinity, and low toxicity. The global antibody production market is driven by key factors including patent cessation of monoclonal antibodies, gradual government acceptance for various targeted immunotherapy, and antibody therapeutics to treat several chronic diseases like cancer, and rheumatic arthritis. Rapid growth in the pharmaceutical and biotechnology sector, growing adoption of protein therapeutics, and availability of enhanced technology for antibody production are also fueling global market growth. 

However, factors such as costly primary antibodies and a low number of commercially available antibody drugs are expected to hamper overall market growth during the forecast period.  

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1404

Key highlights in the report:

  • The polyclonal antibodies segment is projected to account for significant revenue growth between 2021 and 2028. High demand for polyclonal antibodies is due to its quick production, comparatively easy purification, cost-effectiveness, and high chances of getting better antigen response by producing antibodies in various animals. 
  • Based on the process, the downstream process is expected to account for lucrative growth throughout the forecast period. High usage of chromatography systems for production of antibodies is an essential factor boosting segment revenue growth. The downstream process is commonly used owing to high accuracy and efficiency. 
  • Among the end-use segments, the research institutes segment is projected to account for rapid revenue growth during the forecast period owing to rising investments in R&D activities, increasing research on genomics and proteomics, and increasing focus on identifying new biomarkers. 
  • North America accounted for largest revenue share in 2020 and is expected to maintain its dominant position throughout the forecast period. Presence of dominant pharmaceutical and biotechnology companies, technological advancements, availability of latest equipment, well-developed healthcare infrastructure and facilities, increasing investments in R&D, and high focus on drug discovery are key factors fueling market growth in this region.
  • Europe is expected to account for significant revenue growth over the forecast period owing to presence of leading key players, rising prevalence of contagious diseases, and ongoing research activities. 
  • The antibody production market in Asia Pacific is projected to register fastest revenue CAGR over the forecast period. Increasing incidence of various chronic diseases, improving healthcare infrastructure and other facilities, and increasing research and development activities are some factors supporting market revenue growth in Asia Pacific.
  • Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Abcam PLC, and Sigma Aldrich Corporation are some key players operating in the global antibody production market.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1404

For this study, Reports and Data has segmented the global antibody production market based on class, process, end-use, and region:

Class Outlook (Revenue, USD Billion, 2018 - 2028)

  • Monoclonal antibodies
  • Polyclonal Antibodies
  • Murine
  • Chimeric
  • Humanized

Process Outlook (Revenue, USD Billion, 2018 - 2028)

  • Upstream Processing
    • Bioreactors 
      • Large-scale bioreactors
      • Single-use bioreactors 
    • Consumables 
      • Media 
      • Buffers and Reagents 
  • Downstream Processing
    • Chromatography Systems
    • Chromatography Resins 
  • Filtration
    • Filtration Systems
    • Filtration Consumables and Accessories 

End-Use Outlook (Revenue, USD Billion, 2018 - 2028)

  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Research Institutes
  • Others

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1404

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Gene Synthesis Market Size, Share & Analysis, By Product Type (Gene Library Synthesis, Custom Gene Synthesis), By End-Use (Research Organizations, Academic & Research Institutes, Biopharmaceutical Companies), By Region, Forecast To 2027

Biobanks Market By Type (Disease-Oriented Biobanks, Population-Based Biobanks), By Storage Type (Manual Storage, Automated Storage), By Product, By Specimen Type And By Application, Forecasts To 2027

Biomaterials Market Size, Share, Analysis By Type (Metallic, Natural, Ceramic, Polymeric), By Application (Cardiovascular, Ophthalmology, Orthopedic, Plastic Surgery, Neurology), And Region, Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-antibody-production-market

Back to news